Brookfield Corp’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-54,307
Closed -$4.1M 607
2023
Q1
$4.1M Buy
+54,307
New +$4.1M 0.02% 325
2022
Q3
Sell
-126,288
Closed -$6.6M 646
2022
Q2
$6.6M Buy
126,288
+95,772
+314% +$5.44M 0.03% 206
2022
Q1
$1.73M Sell
30,516
-75,679
-71% -$4.05M 0.01% 419
2021
Q4
$5.47M Buy
106,195
+90,330
+569% +$4.43M 0.02% 204
2021
Q3
$785K Sell
15,865
-30,720
-66% -$1.67M ﹤0.01% 445
2021
Q2
$2.66M Sell
46,585
-30,416
-40% -$1.78M 0.01% 311
2021
Q1
$4.68M Buy
77,001
+45,528
+145% +$2.51M 0.02% 173
2020
Q4
$1.69M Sell
31,473
-15,291
-33% -$793K 0.01% 308
2020
Q3
$2.2M Sell
46,764
-23,301
-33% -$1.2M 0.01% 231
2020
Q2
$3.66M Buy
+70,065
New +$3.61M 0.02% 164

Other funds holding CAH

Brookfield Corp's CAH Position: Q2 2023 in Review

Brookfield Corp sold out of Cardinal Health (CAH) in Q2 2023, closing a stake of 54,307 shares — an estimated $4.1M sold.

Brookfield Corp first reported a position in CAH in Q2 2020 and held it in 10 quarters. The position peaked at $6.6M in Q2 2022. 948 funds tracked by Wall St. Rank hold CAH as of Q2 2023.

  • Brookfield Corp reported no remaining Cardinal Health position as of Q2 2023 after selling out during the quarter.
  • Brookfield Corp sold 54,307 Cardinal Health shares in Q2 2023, an estimated $4.1M.
  • Brookfield Corp first reported a position in Cardinal Health in Q2 2020 and held it in 10 quarters.
  • Brookfield Corp's Cardinal Health position peaked at $6.6M in Q2 2022.
  • 948 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2023.

Based on Brookfield Corp's 13F filing for Q2 2023, filed 14 Aug 2023.